Strumento inattivo

Pubblicazioni ufficiali Galapagos NV Euronext Bruxelles

Azioni

Tempo reale stimato Tradegate Altri mercati azionari 14:01:09 05/06/2024			Variaz. 5gg	Var. 1 gen.
25,2 ^EUR	0,00%		0,00%	0,00%

31/05	Galapagos, Adaptimmune svilupperanno congiuntamente un trattamento per il cancro della testa e del collo	MT
30/05	Galapagos e Adaptimmune firmano un accordo di collaborazione clinica con un'opzione di licenza esclusiva per il candidato alla terapia cellulare TCR di Adaptimmune, uza-cel	CI

1st quarter results	02/05	CO
Minutes of the general assembly	30/04	CO
Annual ESG Report	29/03	CO
Annual ESG Report	28/03	CO
Mixed general shareholder meeting	28/03	CO
Mixed general shareholder meeting	28/03	CO
Annual Report	28/03	CO
Annual Report	28/03	CO
Changes in management and corporate officers	26/03	CO
Changes in management and corporate officers	26/03	CO
Annual results	22/02	CO
Annual results	22/02	CO
Changes in management and corporate officers	06/12	CO
3rd quarter results	02/11	CO
3rd quarter results	02/11	CO
Changes in management and corporate officers	19/09/23	CO
Changes in management and corporate officers	19/09/23	CO
1st-half-year results	03/08/23	CO
Half-year report	03/08/23	CO
Half-year report	03/08/23	CO
Changes in management and corporate officers	15/06/23	CO
Changes in management and corporate officers	15/06/23	CO
Changes in management and corporate officers	12/06/23	CO
Changes in management and corporate officers	12/06/23	CO
Minutes of the general assembly	10/05/23	CO